Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy

A. Abed, Adnan Khattak, M. Millward, A. Chopra, E. Gray

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Article number	LBA14
Number of pages	1
Journal	Annals of Oncology
Volume	30
Issue number	Supplement 9
Publication status	Published - Nov 2019
Event	European-Society-for-Medical-Oncology (ESMO) Asia Congress - Singapore, Singapore Duration: 22 Nov 2019 → 24 Nov 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{69602aa7b75c4c668155231193dbd81e,

title = "Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy",

author = "A. Abed and Adnan Khattak and M. Millward and A. Chopra and E. Gray",

year = "2019",

month = nov,

language = "English",

volume = "30",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "Supplement 9",

note = "European-Society-for-Medical-Oncology (ESMO) Asia Congress ; Conference date: 22-11-2019 Through 24-11-2019",

}

TY - JOUR

T1 - Genomic HLA heterozygosity as a predictive marker for survival in lung cancer patients post immunotherapy

AU - Abed, A.

AU - Khattak, Adnan

AU - Millward, M.

AU - Chopra, A.

AU - Gray, E.

PY - 2019/11

Y1 - 2019/11

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 9

M1 - LBA14

T2 - European-Society-for-Medical-Oncology (ESMO) Asia Congress

Y2 - 22 November 2019 through 24 November 2019

ER -